Investors Signal Strong Demand for Next‑Generation ETF Structures and Expanded Investment Strategies: BBH Investor Services 2026 Global ETF Investor Survey
3.3.2026 15:00:00 CET | Business Wire | Press Release
Brown Brothers Harriman (BBH) Investor Services’ 13th annual Global ETF Investor Survey of institutional investors, fund managers, and financial advisors highlights strong enthusiasm for new ETF structures, even as investors refocus on fundamentals to generate alpha amid heightened market volatility. This year’s findings show that 96% of investors plan to increase their ETF allocations over the next 12 months, matching last year’s record‑high level and reinforcing the ETF structure’s central role in portfolios during periods of market uncertainty.
Investors are reshuffling portfolios to accommodate more active ETFs: 53% will reduce index-based ETF allocations, and nearly half will cut index and actively managed mutual funds. With active ETF assets nearing $2 trillion, 94% believe they’ll top $10 trillion within a decade, and 77% expect this milestone in seven years.
“ETF issuers are innovating to meet the evolving needs of today’s investors,” said Tim Huver, Managing Director on the ETF Servicing Team at BBH. “The next phase of ETF product growth will look very different from the prior decade, with greater emphasis on active management, expanded access to new asset classes, and the operational sophistication required to support more complex strategies at scale.”
Appetite for innovation is surging: 82% would consider ETF share classes of mutual funds, while 99% are open to private markets ETFs, signaling demand for broader access and efficiency.
Additional Key Findings
- 63% plan to work with more ETF issuers.
- 65% say ETF issuers stand out with superior client service and support.
- 58% don’t believe tokenization will fundamentally change financial markets.
- 17% intend to invest in cryptocurrency ETFs, though performance outlooks for crypto assets have dropped sharply since last year.
- Investors expect increased allocations to dividend/income (33%), sector/thematic (28%), defined outcome (26%), and money market ETFs (20%).
- Regional trends persist: U.S. leads in ETF adoption, Greater China sees notable growth, and Europe focuses on income, diversification, and risk management amid regulatory shifts.
Industry thought leaders Deborah Fuhr (ETFGI) and Elias Haddad (BBH) provide additional insights on active ETF growth, market trends, and how macroeconomic factors may shape ETF flows in 2026.
The full 2026 Global ETF Investor Survey is available at BBH.com. The survey was conducted by Wakefield Research on behalf of BBH and included 325 professional ETF investors across the U.S., Greater China, and Europe, representing institutional investors, financial advisors, fund management firms, private banks, and wealth management organizations.
About Brown Brothers Harriman (BBH)
Brown Brothers Harriman (BBH) is a global financial services firm known for premium service and specialist expertise. For more than 200 years, BBH has partnered with clients to navigate complexity, innovate with purpose, and succeed in evolving financial markets. Its 6,000 employees serve clients and their investments in more than 90 markets from 18 offices worldwide. As a private partnership, BBH is uniquely structured to put clients first and deliver success that lasts.
BBH Investor Services is a leading provider of asset servicing and operating model solutions to global asset managers and financial institutions. Asset servicing capabilities include custody, global tax services, depositary and trustee services, fund accounting, administration, and transfer agency. Operating model solutions address platform, data, and connectivity challenges across open‑architecture environments, helping clients drive growth, operational efficiency, and resiliency while enhancing reporting and oversight. BBH has been servicing ETFs for over two decades.
References to specific types of securities and asset classes are for informational purposes only and are not intended to be, and should not be interpreted as, investment recommendations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260303929711/en/
Contacts
Prosek Partners (on behalf of BBH)
pro-bbh@prosek.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting Strengthens Digital Transformation Capabilities with Weexa30.4.2026 15:30:00 CEST | Press Release
Andersen Consulting enters into a Collaboration Agreement with Weexa, a global provider of digital transformation, B2B integration, and supply chain digitalization solutions. Headquartered in France, Weexa delivers end-to-end services that help organizations streamline, secure, and scale their digital ecosystems. The firm specializes in B2B data-flow management and digitalization, enabling seamless communication between applications both within and across organizations through technologies such as EDI, APIs, and e-invoicing. Weexa also provides SAP integration and supply chain solutions spanning warehouse and transport management, alongside strategic consulting, project delivery, and third-party application maintenance. Serving organizations across the food, retail, wholesale, logistics, transportation, automotive, healthcare, and media sectors, Weexa supports global businesses in optimizing performance while meeting evolving regulatory and digital-compliance requirements. “Collaborati
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 15:22:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et
Experian Announces Agent Trust to Power Trusted AI Driven Commerce30.4.2026 15:00:00 CEST | Press Release
Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430719198/en/ Experian Announces Agent Trust to Power Trusted AI Driven Commerce. As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions. Experian Agent Trust addresses this challenge through a new “Know Your Agent” (KYA) framework, extending identity verification into the age of AI. The framework ensures that agent-initiated transactions are grounded in verified consumer identity. “Agen
Meet the AI-powered fan companion: TGR Haas F1 Team RaceMate powered by Infobip30.4.2026 15:00:00 CEST | Press Release
Global AI-first cloud communications platform Infobip and TGR Haas F1 team are launching ‘TGR Haas F1 Team RaceMate powered by Infobip’, an AI-powered conversational fan companion on Apple Messages for Business and WhatsApp Business Platform. Always-on and always available, it delivers race intelligence for TGR Haas F1 Team: team race intelligence, grid positions, qualifying outcomes, sprint results, and full session schedules. The AI agent tracks drivers Ollie Bearman and Esteban Ocon with their individual championship standings and performance data in conversational format. The agent draws from a knowledge base covering driver biographies, team history, and circuit data, adapting to each user's knowledge level. Every interaction begins with a schedule check, ensuring fans always know what's happening right now. It proactively surfaces relevant information, suggests next actions, and maintains conversational flow to keep every interaction effortless and engaging. Delivered in short, s
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 14:05:00 CEST | Press Release
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People living with lupus continue to face significant challenges in achieving disease control and are very often affected by itchy, painful and stigmatized skin manifestations,” said David Weinreich, Global Head of R&D, Merck. “With enpatoran, we aim to target the underlying drivers of lupus and redefine how to approach the disease by understanding both visible skin manifestations and systemic activity.” Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor designed to modulate pathways central to lupus-related inflammatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom